论文部分内容阅读
目的分析磺胺嘧啶银乳膏联合金因肽在糖尿病足治疗中的临床效果。方法将从2015年3月—2016年11月在该院就诊的60例糖尿病患者按照数字随机表法随机分为对照组和实验组,每组各有30例患者;对照组采用常规治疗,实验组为磺胺嘧啶银乳膏联合金因肽治疗;对比分析两组临床疗效。结果实验组有1例无效,有效率为96.67%;对照组有5例无效,有效率为83.33%;实验组患者的有效率显著的高于对照组(P<0.05)。结论在糖尿病足临床治疗中,磺胺嘧啶银乳膏联合金因肽治疗疗效较为显著,具有应用价值。
Objective To analyze the clinical effect of sulfadiazine silver cream combined with gold peptide in the treatment of diabetic foot. Methods Sixty diabetic patients treated in this hospital from March 2015 to November 2016 were randomly divided into control group and experimental group according to the digital random table method, and each group had 30 patients. The control group was treated with routine therapy Group of silver sulfadiazine cream combined with gold peptide treatment; comparative analysis of two groups of clinical curative effect. Results In the experimental group, 1 patient was ineffective and the effective rate was 96.67%. In the control group, 5 patients were ineffective and the effective rate was 83.33%. The effective rate of the experimental group was significantly higher than that of the control group (P <0.05). Conclusion In the clinical treatment of diabetic foot, silver sulfadiazine cream combined with gold peptide treatment is more effective and has application value.